These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 3875606

  • 21. In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
    Dornbusch K, Adamsson L, Gezelius L, Hallander H.
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():113-21. PubMed ID: 6460739
    [No Abstract] [Full Text] [Related]

  • 22. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC, Chin NX, Jules K, Labthavikul P.
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
    Qadri SM, Ueno Y, Burdette M, Kroschinsky R, Almodovar E.
    Chemotherapy; 1991 Apr; 37(6):398-404. PubMed ID: 1760938
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX, Zhang YX, Neu HC.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(5):417-24. PubMed ID: 1797456
    [Abstract] [Full Text] [Related]

  • 25. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
    Cheng AF, Ling TK, Lam AW, Fung KS, Wise R.
    J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
    [Abstract] [Full Text] [Related]

  • 26. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I, Warren C, Shannon K, King A, Hanslo D.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [Abstract] [Full Text] [Related]

  • 27. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T, Retsema J, Girard A, Hamanaka E, Anderson M, Sokolowski S.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
    Neu HC, Chin NX, Saha G, Labthavikul P.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
    [Abstract] [Full Text] [Related]

  • 29. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
    [Abstract] [Full Text] [Related]

  • 30. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R, Altamura M, Arcamone F, Mazzariol A, Morandotti G, Sperning R, Cornaglia G.
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [Abstract] [Full Text] [Related]

  • 31. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Kundargi R.
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
    [Abstract] [Full Text] [Related]

  • 32. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
    Verbist L.
    J Antimicrob Chemother; 1986 Sep; 18(3):351-8. PubMed ID: 3095299
    [Abstract] [Full Text] [Related]

  • 33. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [Abstract] [Full Text] [Related]

  • 34. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX, Neu HC.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of CGP 31608, a new penem.
    Wise R, Andrews JM, Piddock LJ.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [Abstract] [Full Text] [Related]

  • 36. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Feb; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 37. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A, Jungwirth R, Schweighart S.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [Abstract] [Full Text] [Related]

  • 38. Cefpiramide: comparative in-vitro activity and beta-lactamase stability.
    Barry AL, Jones RN, Thornsberry C, Fuchs PC, Ayers LW, Gavan TL, Gerlach EH, Sommers HM.
    J Antimicrob Chemother; 1985 Sep; 16(3):315-25. PubMed ID: 3877041
    [Abstract] [Full Text] [Related]

  • 39. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
    van Klingeren B.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
    [Abstract] [Full Text] [Related]

  • 40. Comparative in-vitro activity of Sch 34343, a new penem antibiotic.
    Reeves DS, Holt HA, Bywater MJ.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():57-66. PubMed ID: 3849538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.